Company Extends and Expands Its Credit Capacity Through the Establishment of Two Term LoansForecasts Adjusted EBITDA in a range of $44 - $48 million in 2026Announces the Company will be rationalizing ...
Fourth Quarter Revenues of RMB 676.2 million, down 17.4% year over year -- Fourth Quarter Net Loss of RMB 88.1 million, compared with RMB 72.5 million in the same period of 2024 -- Full Year Revenues ...
Introduction A disproportionate share of global neonatal deaths occurs in armed-conflict settings, where progress in reducing neonatal mortality remains slow. This systematic review aims to synthesise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results